default author photo

Jean William Pape

Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO)

SCHOLARLY PAPERS

3

DOWNLOADS

334

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Ritonavir-Boosted Protease Inhibitor-Based Antiretroviral Therapy in Persons with HIV and Viral Suppression on Second-Line Therapy: An Open-Label Randomized Non-Inferiority Trial

Number of pages: 27 Posted: 02 Jan 2025
Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Harvard University - Department of Global Health and Social Medicine, Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Analysis Group, Inc., Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Analysis Group, Inc., Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), National Institute of Respiratory Diseases ”Ismael Cosío Villegas” - Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Analysis Group, Inc., Gilead Sciences, Inc., Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Cornell University, Analysis Group, Inc., Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Gilead Sciences, Inc., Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Harvard University - Division of Infectious Disease and Harvard University - Harvard Medical School
Downloads 146 (505,974)

Abstract:

Loading...

HIV, INSTI, bictegravir, protease inhibitor, tenofovir alafenamide, tenofovir disoproxil fumarate

2.

High Rates of Retention and Viral Suppression with a Model of Community-Based HIV Care in a Setting of Severe Civil Unrest

Number of pages: 19 Posted: 27 Feb 2024
Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Harvard University, Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), University of California, San Francisco (UCSF), Analysis Group, Inc., Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO) and Harvard University
Downloads 96 (709,832)

Abstract:

Loading...

community-based HIV care, HIV service delivery in civil unrest, differentiated service delivery models, health service provision during conflict, health systems resilience

3.

Temporal Trends in Tuberculosis and the Time from Enrollment in Care to Antiretroviral Therapy Initiation Among People Living with HIV in Latin America

Number of pages: 23 Posted: 10 Feb 2025
Vanderbilt University Medical Center - Department of Biostatistics, Vanderbilt University - Medical Center, Vanderbilt University - Medical Center, Instituto de Investigaciones Clínicas Zárate, Oswaldo Cruz Foundation (FIOCRUZ) - Instituto Nacional de Infectologia Evandro Chagas (INIEC), University of Chile - Faculty of Medicine, Hospital Escuela, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Universidad Peruana Cayetano Heredia, Vanderbilt University - Medical Center, Vanderbilt University - Medical Center, Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Vanderbilt University - Division of Infectious Diseases and Harvard University - Harvard Medical School
Downloads 92 (730,864)

Abstract:

Loading...

HIV, Tuberculosis, Antiretroviral Therapy, Same-Day Treatment, Latin America, Caribbean